市场调查报告书
商品编码
1422697
低强度甜味剂市场规模-依产品类型(赤藻醣醇、麦芽糖醇、木糖醇、DTagatose、山梨醇、甘露糖醇、阿洛酮糖)、来源(天然、合成)、应用(食品和饮料、药品、个人护理)和全球预测,2024-2032Low Intensity Sweeteners Market Size-By Product Type (Erythritol, Maltitol, Xylitol, DTagatose, Sorbitol, Mannitol, Allulose), Source (Natural, Synthetic), Application (Food & Beverages, Pharmaceuticals, Personal Care) & Global Forecast, 2024-2032 |
在食品技术进步以及食品和饮料配方减糖趋势的推动下,2024年至2032年全球低强度甜味剂市场CAGR将达到4.7%。随着消费者越来越重视健康,製造商正在利用创新的解决方案来满足对低热量替代品的需求。尖端食品技术的整合使得能够开发出有吸引力的低糖产品。技术进步与人们普遍追求更健康的选择之间的协同作用将极大地促进市场成长。
该公司正在积极开发低热量糖替代品并推出新产品,从而扩大市场份额。例如,2023 年,Tate & Lyle Sugars 将三氯蔗糖纳入其甜味剂系列。这一添加提供了蔗糖 70% 的甜度,满足了对低热量糖替代品不断增长的需求。
低强度甜味剂产业根据产品、应用和地区进行分类。
由于山梨醇的多功能性和天然来源,到 2032 年,山梨醇细分市场将获得显着增长,使其成为寻求低热量选择的注重健康的消费者的首选。山梨糖醇能够复製糖的甜味,而不会产生相关的热量影响,因此满足了对更健康甜味替代品不断增长的需求。山梨醇细分市场的主导地位凸显了其在满足消费者和更广泛的食品和饮料行业不断变化的偏好方面的关键作用。
到2032 年,製药领域的低强度甜味剂市场规模将大幅成长。随着注重健康的消费者越来越多地寻求糖替代品,製药业在各种配方中使用低强度甜味剂有助于实现这一主导地位。製药业专注于创造美味的药物和补充剂,正在推动对这些甜味剂的需求。它们在增强口服药物的味道同时最大限度地减少热量摄取方面发挥着重要作用,使製药业成为不断扩大的低强度甜味剂市场的重要参与者。
在消费者健康意识增强的推动下,欧洲低强度甜味剂产业将在 2024 年至 2032 年呈现显着的复合CAGR,促使人们转向低糖替代品。对食品和饮料中糖含量的严格监管进一步刺激了该地区对低强度甜味剂的需求。作为这一市场趋势的重要贡献者,欧洲反映出更健康的甜味剂选择在食品和饮料行业中日益重要。
Global Low Intensity Sweeteners Market will register a 4.7% CAGR from 2024 to 2032, propelled by advancements in food technology and the surging trend of sugar reduction in food and beverage formulations. As consumers increasingly prioritize health, manufacturers are leveraging innovative solutions to meet the demand for low-calorie alternatives. The integration of cutting-edge food technology enables the development of appealing products with reduced sugar content. This synergy between technological advancements and the prevalent drive toward healthier choices will contribute significantly to the market growth.
Companies are actively formulating low-calorie sugar substitutes and introducing new product offerings, thus strengthening their market share. For instance, in 2023, Tate & Lyle Sugars incorporated sucralose into its range of sweeteners. This addition, offering 70% of the sweetness of sucrose, caters to the growing demand for low-calorie sugar alternatives.
The low intensity sweeteners industry is classified based on product, application, and region.
The sorbitol segment will garner remarkable gains by 2032, attributed to sorbitol's versatility and natural origin, making it a preferred choice for health-conscious consumers seeking reduced-calorie options. With the ability to replicate sugar's sweetness without the associated caloric impact, sorbitol aligns with the rising demand for healthier sweetening alternatives. The dominance of the sorbitol segment underscores its pivotal role in meeting the evolving preferences of consumers and the broader food and beverage industry.
The low intensity sweeteners market size from the pharmaceuticals segment will witness a substantial upswing by 2032. As health-conscious consumers increasingly seek sugar alternatives, the pharmaceutical industry's utilization of low-intensity sweeteners in various formulations contributes to this dominance. With an emphasis on creating palatable medications and supplements, the pharmaceutical segment is driving demand for these sweeteners. Their role in enhancing the taste of oral medications while minimizing caloric intake positions the pharmaceuticals segment as a significant player in the expanding low intensity sweeteners market.
Europe low intensity sweeteners industry will demonstrate a significant CAGR from 2024 to 2032, driven by heightened consumer awareness of health and wellness, prompting a shift toward reduced-sugar alternatives. Stringent regulations on sugar content in food and beverages further boost the demand for low-intensity sweeteners in the region. As a significant contributor to this market trend, Europe reflects the growing importance of healthier sweetening options in the food and beverage industry.